Clinical Trials Browser

Phase 2 × Terminated × Carcinoma, Small Cell × Clear all

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Prostatic Neoplasms, Castration-Resistant

NCT04926181 2025-05-15

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

Phase 2 Terminated

2 enrolled 12 charts

GenitourinaryThoracic

Prostatic Neoplasms, Carcinoma, Small Cell, Bulbo-Spinal Atrophy, X-Linked, Small Cell Lung Carcinoma

NCT02608411 2023-10-13

TIMES

Phase 2 Terminated

5 enrolled

Carcinoma, Small Cell

NCT00129974 2017-06-16

Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer

Phase 2 Terminated

1 enrolled 3 charts

Thoracic

Lung Neoplasms, Carcinoma, Small Cell

NCT00324558 2012-06-08

Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)

Phase 2 Terminated

39 enrolled

Thoracic

Carcinoma, Small Cell, Small Cell Lung Carcinoma

Clinical Trials

Tamarack

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

TIMES

Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer

Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)